자동 굴절검사기 및 각막측정기 시장 규모, 점유율, 성장 및 세계 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2024-2032년)

Growth Factors of autorefractor and keratometer Market

The global autorefractor and keratometer market continues to expand steadily due to rising ophthalmic disorders, increasing adoption of diagnostic equipment, and strong technological advancements in eye-care devices. The market was valued at USD 69.7 million in 2024, is expected to reach USD 73.3 million in 2025, and is projected to surge to USD 107.1 million by 2032, reflecting strong growth across ophthalmic practices worldwide. North America led the market in 2024 with a 35% share, supported by advanced healthcare infrastructure and major players expanding their diagnostic portfolios.

Market Overview

Autorefractors and keratometers are essential ophthalmic diagnostic instruments used to measure refractive error and corneal curvature, respectively. Combined units, known as autorefractor-keratometers (ARKs), provide comprehensive vision assessment for hyperopia, myopia, astigmatism, and other refractive issues. Demand for these devices is steadily rising due to the global burden of vision disorders and increased emphasis on early detection.

The market is supported by leading manufacturers such as Topcon Corporation, Carl Zeiss Meditech AG, NIDEK CO., LTD., Canon Medical Systems, and EssilorLuxottica, all investing heavily in technology advancements and product expansion strategies.

Market Drivers

Growing Burden of Eye Disorders

The prevalence of ocular diseases such as astigmatism, hyperopia, and cataracts is accelerating. Lifestyle changes, increased screen time, and age-related degeneration contribute to a growing population requiring vision correction. According to NCBI (September 2023), nearly 50% of the global population is expected to have myopia by 2050, with 10% becoming highly myopic. This rising burden necessitates advanced eye-diagnostic solutions, boosting demand for autorefractors and keratometers.

Push for Early and Accurate Diagnosis

Governments and healthcare institutions are increasing investments in early detection programs to manage preventable blindness. Early refractive error screening allows timely treatment, positively raising the demand for advanced ophthalmic equipment.

Market Restraints

A key challenge in developing economies is limited awareness regarding regular eye examinations, combined with affordability issues. High-end autorefractors costing up to USD 25,000, as cited by Bimedis (2025), are often unaffordable for smaller clinics, slowing market penetration in cost-sensitive regions. The lack of trained ophthalmic technicians in several countries also reduces device utilization.

Market Opportunities

Strategic collaborations among major players are accelerating innovation. In April 2024, Carl Zeiss Meditech acquired D.O.R.C., strengthening its ophthalmic workflow and product portfolio. Such partnerships support the launch of more advanced devices, including handheld and AI-enabled systems, creating strong growth opportunities through 2032.

Market Trends

Technological advancements-including digital imaging, AI-powered diagnostics, machine learning, automated focusing, cloud data storage, and EHR integration-are reshaping the industry. Modern devices can capture high-resolution corneal images, detect subtle anatomical changes, and provide automated results, improving clinical accuracy and efficiency. These innovations are positioning ARKs as indispensable tools in modern eye-care practices.

Segmentation Insights

By Product Type

• Hybrid autorefractor-keratometers dominate the market due to higher accuracy and multifunctionality.
• The autorefractor segment is rising rapidly with AI-powered and ergonomic designs.

By Portability

• Tabletop models lead due to their use in diagnostic centers and hospitals.
• Handheld devices are growing quickly, supported by portable solutions such as Remidio's Instaref R20.

By Indication

Hyperopia held the largest share in 2024, with Cleveland Clinic estimating it affects 4.6% of children and 30.9% of adults globally. Myopia and astigmatism are expected to grow significantly due to increased screen exposure.

By End User

Hospitals dominated in 2024 due to high procedure volume, while ophthalmic clinics are growing fastest with the expansion of specialty eye-care centers.

Regional Overview

North America

The region generated USD 24.4 million in 2024, driven by strong adoption in the U.S. and Canada. High diabetic population rates and increased ocular complications are pushing demand for precision diagnostic tools.

Europe

Europe maintains a strong market due to strict medical device regulations and a large ophthalmologist base. The U.K. had 3,377 ophthalmologists registered in December 2023.

Asia Pacific

Expected to grow at the fastest CAGR. Rising cases of refractive errors-such as 47.8% astigmatism in South Delhi school children (2022)-are driving demand for advanced diagnostics.

Latin America & Middle East/Africa

Moderate growth driven by healthcare investments, including Saudi Arabia's USD 65B Vision 2030 health program.

Conclusion

With a rise from USD 69.7 million (2024) to USD 107.1 million by 2032, the autorefractor and keratometer market is poised for strong, sustained growth. Increasing ocular diseases, technological advancements, and expanding healthcare infrastructure worldwide will continue to propel the market through the forecast period.

Segmentation By Product Type

• Autorefractor
• Keratometer
• Hybrid

By Portability

• Tabletop
• Handheld

By Indication

• Hyperopia
• Myopia
• Astigmatism
• Others

By End-user

• Hospitals
• Ophthalmic Clinics
• Others

By Region

• North America (By Product Type, Portability, Indication, End-user, and Country)
  • U.S.
  • Canada
• Europe (By Product Type, Portability, Indication, End-user, and Country/Sub-region)
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Product Type, Portability, Indication, End-user, and Country/Sub-region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Product Type, Portability, Indication, End-user, and Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Product Type, Portability, Indication, End-user, and Country/Sub-region)
  • GCC
  • South Africa
  • Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Key Conditions, By Key Countries/Region, 2024
• 4.2. Key Industry Developments - (Mergers, Acquisitions & Partnerships, etc.)
• 4.3. New Product Launch/Approvals, By Key Players

5. Global Autorefractor and Keratometer Market Analysis, Insights and Forecast, 2019-2032

• 5.1. Market Analysis, Insights and Forecast - By Product Type
  • 5.1.1. Autorefractor
  • 5.1.2. Keratometer
  • 5.1.3. Hybrid
• 5.2. Market Analysis, Insights and Forecast - By Portability
  • 5.2.1. Tabletop
  • 5.2.2. Handheld
• 5.3. Market Analysis, Insights and Forecast - By Indication
  • 5.3.1. Hyperopia
  • 5.3.2. Myopia
  • 5.3.3. Astigmatism
  • 5.3.4. Others
• 5.4. Market Analysis, Insights and Forecast - By End-user
  • 5.4.1. Hospitals
  • 5.4.2. Ophthalmic Clinics
  • 5.4.3. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Autorefractor and Keratometer Market Analysis, Insights and Forecast, 2019-2032

• 6.1. Market Analysis, Insights and Forecast - By Product Type
  • 6.1.1. Autorefractor
  • 6.1.2. Keratometer
  • 6.1.3. Hybrid
• 6.2. Market Analysis, Insights and Forecast - By Portability
  • 6.2.1. Tabletop
  • 6.2.2. Handheld
• 6.3. Market Analysis, Insights and Forecast - By Indication
  • 6.3.1. Hyperopia
  • 6.3.2. Myopia
  • 6.3.3. Astigmatism
  • 6.3.4. Others
• 6.4. Market Analysis, Insights and Forecast - By End-user
  • 6.4.1. Hospitals
  • 6.4.2. Ophthalmic Clinics
  • 6.4.3. Others
• 6.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Autorefractor and Keratometer Market Analysis, Insights and Forecast, 2019-2032

• 7.1. Market Analysis, Insights and Forecast - By Product Type
  • 7.1.1. Autorefractor
  • 7.1.2. Keratometer
  • 7.1.3. Hybrid
• 7.2. Market Analysis, Insights and Forecast - By Portability
  • 7.2.1. Tabletop
  • 7.2.2. Handheld
• 7.3. Market Analysis, Insights and Forecast - By Indication
  • 7.3.1. Hyperopia
  • 7.3.2. Myopia
  • 7.3.3. Astigmatism
  • 7.3.4. Others
• 7.4. Market Analysis, Insights and Forecast - By End-user
  • 7.4.1. Hospitals
  • 7.4.2. Ophthalmic Clinics
  • 7.4.3. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.5.1. U.K.
  • 7.5.2. Germany
  • 7.5.3. France
  • 7.5.4. Spain
  • 7.5.5. Italy
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Autorefractor and Keratometer Market Analysis, Insights and Forecast, 2019-2032

• 8.1. Market Analysis, Insights and Forecast - By Product Type
  • 8.1.1. Autorefractor
  • 8.1.2. Keratometer
  • 8.1.3. Hybrid
• 8.2. Market Analysis, Insights and Forecast - By Portability
  • 8.2.1. Tabletop
  • 8.2.2. Handheld
• 8.3. Market Analysis, Insights and Forecast - By Indication
  • 8.3.1. Hyperopia
  • 8.3.2. Myopia
  • 8.3.3. Astigmatism
  • 8.3.4. Others
• 8.4. Market Analysis, Insights and Forecast - By End-user
  • 8.4.1. Hospitals
  • 8.4.2. Ophthalmic Clinics
  • 8.4.3. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.5.1. Japan
  • 8.5.2. China
  • 8.5.3. India
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Autorefractor and Keratometer Market Analysis, Insights and Forecast, 2019-2032

• 9.1. Market Analysis, Insights and Forecast - By Product Type
  • 9.1.1. Autorefractor
  • 9.1.2. Keratometer
  • 9.1.3. Hybrid
• 9.2. Market Analysis, Insights and Forecast - By Portability
  • 9.2.1. Tabletop
  • 9.2.2. Handheld
• 9.3. Market Analysis, Insights and Forecast - By Indication
  • 9.3.1. Hyperopia
  • 9.3.2. Myopia
  • 9.3.3. Astigmatism
  • 9.3.4. Others
• 9.4. Market Analysis, Insights and Forecast - By End-user
  • 9.4.1. Hospitals
  • 9.4.2. Ophthalmic Clinics
  • 9.4.3. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Autorefractor and Keratometer Market Analysis, Insights and Forecast, 2019-2032

• 10.1. Market Analysis, Insights and Forecast - By Product Type
  • 10.1.1. Autorefractor
  • 10.1.2. Keratometer
  • 10.1.3. Hybrid
• 10.2. Market Analysis, Insights and Forecast - By Portability
  • 10.2.1. Tabletop
  • 10.2.2. Handheld
• 10.3. Market Analysis, Insights and Forecast - By Indication
  • 10.3.1. Hyperopia
  • 10.3.2. Myopia
  • 10.3.3. Astigmatism
  • 10.3.4. Others
• 10.4. Market Analysis, Insights and Forecast - By End-user
  • 10.4.1. Hospitals
  • 10.4.2. Ophthalmic Clinics
  • 10.4.3. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.5.1. GCC
  • 10.5.2. South Africa
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2024)
• 11.2. Company Profiles
  • 11.2.1. Carl Zeiss Meditech AG
    • 11.2.1.1. Overview
    • 11.2.1.2. Products
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. EssilorLuxottica
    • 11.2.2.1. Overview
    • 11.2.2.2. Products
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Topcon Corporation
    • 11.2.3.1. Overview
    • 11.2.3.2. Products
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. NIDEK CO., LTD.
    • 11.2.4.1. Overview
    • 11.2.4.2. Products
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. Bausch + Lomb
    • 11.2.5.1. Overview
    • 11.2.5.2. Products
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. CANON MEDICAL SYSTEMS CORPORATION
    • 11.2.6.1. Overview
    • 11.2.6.2. Products
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. Remidio Innovative Solutions Pvt Ltd.
    • 11.2.7.1. Overview
    • 11.2.7.2. Products
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. Visionix
    • 11.2.8.1. Overview
    • 11.2.8.2. Products
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)